Protein signatures may help predict malaria severity and guide treatment

Researchers at Karolinska Institutet have identified over 250 proteins that are strongly affected by malaria, which could help predict the severity of the disease and thus enable faster treatment for the most critical patients.

The study, published in the journal Immunity, was conducted on 72 adult travellers diagnosed with malaria at Karolinska University Hospital after returning from tropical regions.

By analysing blood samples from these individuals, who were followed for a year, the researchers were able to identify around 700 proteins that changed during the infection, of which over 250 were strongly affected. In this way, the researchers were able to map proteins in the blood, which made it possible, among other things, to group patients according to the severity of the disease.

"Malaria can quickly become life-threatening, but it is difficult to predict at an early stage which patients are at risk of deterioration. Our results show how a set of proteins can help identify high-risk patients more quickly and enable more effective treatment," says Anna Färnert, professor at the Department of Medicine, Solna, Karolinska Institutet, and senior physician at Karolinska University Hospital, who led the study together with Christopher Sundling at the same institution.

Through data-driven analysis, the researchers were able to link the proteins to specific immune cells and identify the organs from which the proteins originate.

In this study, we have been able to measure such a large number of proteins with high precision in the blood of malaria patients for the first time. This provides completely new and detailed insights into the immune system's response to the infection."

Maximilian Julius Lautenbach, first author, postdoctoral researcher, Department of Medicine, Solna, Karolinska Institutet

The researchers emphasize that further studies are needed to validate these findings in larger patient groups and to explore the potential clinical applications of the protein signatures.

Source:
Journal reference:

Motso, A., et al. (2025). GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity. Cell. doi.org/10.1016/j.cell.2025.05.042.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How a simple blood test can forecast future health risks